Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Following pulmonary embolism (PE), a third of patients develop persistent dyspnea, which is commonly termed the post-PE syndrome. The neurophysiological underpinnings of exertional dyspnea in patients with post-PE syndrome without pulmonary hypertension (PH) are unclear. Thus, the current study determined if abnormally high inspiratory neural drive (IND) due, in part, to residual pulmonary gas-exchange abnormalities, was linked to heightened exertional dyspnea and exercise limitation, in such patients. Fourteen participants with post-PE syndrome (without resting PH) and 14 age- sex- and body mass index-matched healthy controls undertook pulmonary function testing and a symptom-limited cycle cardiopulmonary exercise test with measurements of IND (diaphragmatic electromyography), ventilatory requirements for CO2 (V̇E/V̇CO2), and perceived dyspnea intensity (modified Borg 0-10 scale). Post-PE (vs control) had a reduced resting transfer coefficient for carbon monoxide (KCO: 84±15 vs 104±14%pred, p<0.001) and peak oxygen uptake (V̇O2peak)(76±14 vs 124±28%pred, p<0.001). IND and V̇E/V̇CO2 were higher in post-PE than controls at standardized submaximal work rates (p<0.05). Dyspnea increased similarly in both groups as a function of increasing IND but was higher in post-PE at standardized submaximal work rates (p<0.05). High IND was associated with low KCO (r=-0.484, p<0.001), high V̇E/V̇CO2 nadir (r=0.453, p<0.001) and low V̇O2peak (r=-0.523, p<0.001). In patients with post-PE syndrome, exercise IND was higher than controls and was associated with greater dyspnea intensity. The heightened IND and dyspnea in post-PE, in turn, were strongly associated with low resting KCO and high exercise V̇E/V̇CO2, which suggest important pulmonary gas-exchange abnormalities in this patient population.
Following pulmonary embolism (PE), a third of patients develop persistent dyspnea, which is commonly termed the post-PE syndrome. The neurophysiological underpinnings of exertional dyspnea in patients with post-PE syndrome without pulmonary hypertension (PH) are unclear. Thus, the current study determined if abnormally high inspiratory neural drive (IND) due, in part, to residual pulmonary gas-exchange abnormalities, was linked to heightened exertional dyspnea and exercise limitation, in such patients. Fourteen participants with post-PE syndrome (without resting PH) and 14 age- sex- and body mass index-matched healthy controls undertook pulmonary function testing and a symptom-limited cycle cardiopulmonary exercise test with measurements of IND (diaphragmatic electromyography), ventilatory requirements for CO2 (V̇E/V̇CO2), and perceived dyspnea intensity (modified Borg 0-10 scale). Post-PE (vs control) had a reduced resting transfer coefficient for carbon monoxide (KCO: 84±15 vs 104±14%pred, p<0.001) and peak oxygen uptake (V̇O2peak)(76±14 vs 124±28%pred, p<0.001). IND and V̇E/V̇CO2 were higher in post-PE than controls at standardized submaximal work rates (p<0.05). Dyspnea increased similarly in both groups as a function of increasing IND but was higher in post-PE at standardized submaximal work rates (p<0.05). High IND was associated with low KCO (r=-0.484, p<0.001), high V̇E/V̇CO2 nadir (r=0.453, p<0.001) and low V̇O2peak (r=-0.523, p<0.001). In patients with post-PE syndrome, exercise IND was higher than controls and was associated with greater dyspnea intensity. The heightened IND and dyspnea in post-PE, in turn, were strongly associated with low resting KCO and high exercise V̇E/V̇CO2, which suggest important pulmonary gas-exchange abnormalities in this patient population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.